Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and

Alan J Mueller-Breckenridge1, Fernando Garcia-Alcalde2, Steffen Wildum2

  • 1Roche Innovation Centre, Basel, Switzerland F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070, Basel, Switzerland. alan_james.mueller-breckenridge@roche.com.

Scientific Reports
|December 13, 2019
PubMed

Insights

Hepatitis B virus (HBV) quasispecies diversity was comprehensively surveyed using ultra-deep sequencing. Machine learning models identified viral variants that accurately classify Hepatitis B e antigen (HBeAg) status, aiding chronic HBV infection management.

Area of Science:

  • Virology
  • Genomics
  • Hepatology

Background:

  • Chronic Hepatitis B virus (HBV) infection is a leading cause of liver disease, including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC).
  • Understanding the role of viral genetic diversity in disease progression is crucial for effective management.
  • Current tools for analyzing complex HBV patient viral profiles are limited.

Purpose of the Study:

  • To conduct the first comprehensive survey of HBV quasispecies diversity across European and Asian patient cohorts.
  • To develop a machine learning model for classifying Hepatitis B e antigen (HBeAg) seroconversion status based on viral variants.
  • To explore the utility of advanced analytics for clinical decision support in chronic HBV infection.

Main Methods:

  • Ultra-deep sequencing of the complete HBV genome from European and Asian patient samples.
  • Application of machine learning algorithms to identify viral variants associated with HBeAg status.
  • Comparative analysis of HBV quasispecies populations and their clinical implications.

Main Results:

  • Detailed characterization of HBV quasispecies diversity across diverse patient populations.
  • Development of a predictive model accurately classifying HBeAg status using viral variant signatures.
  • Identification of specific viral mutants correlating with disease progression markers.

Conclusions:

  • Ultra-deep sequencing provides unprecedented insight into HBV quasispecies dynamics.
  • Machine learning effectively leverages viral genetic data for clinical stratification of HBV patients.
  • Advanced analysis of HBV quasispecies can inform therapeutic strategies and improve patient outcomes in chronic infection.